3rd Quarter - Report
ALEXION PHARMACEUTICALS, INC. for ALEXION PHARMACEUTICALS, INC.
Income
—
Expenses
$350,000
Expense method
A: Lobbying Disclosure Act definitions
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
Camp Draft on tax reform Rep. Schwartz Patent Box draft Sen. Feinstein Patent Box draft
| Lobbyist | Covered position, as disclosed |
|---|---|
| VANESSA PROCTER | — |
| HEIDI L WAGNER | — |
Health Issues HCR
Food and Drug Administration Safety and Innovation Act (S. 3187) 2013 sequestration issues
| Lobbyist | Covered position, as disclosed |
|---|---|
| VANESSA PROCTER | — |
| HEIDI L WAGNER | — |
Trade (domestic/foreign) TRD
Korea-US Free Trade Agreement implementation
| Lobbyist | Covered position, as disclosed |
|---|---|
| HEIDI L WAGNER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.